Exact Sciences (EXAS)
(Delayed Data from NSDQ)
$41.88 USD
-0.87 (-2.04%)
Updated Jun 14, 2024 04:00 PM ET
After-Market: $41.90 +0.02 (0.05%) 7:58 PM ET
4-Sell of 5 4
D Value F Growth D Momentum F VGM
Brokerage Reports
Exact Sciences Corporation [EXAS]
Reports for Purchase
Showing records 181 - 200 ( 366 total )
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
MID-DAY SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
Wins FDA Approval; CMS Preliminary National Coverage Decision Process also Begins
Provider: The Benchmark Company
Analyst: WALD J
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
Cologuard Wins FDA Approval, CMS Issues Proposed NCD; Reiterate Buy
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
The Week Ahead in Life Sciences - Upcoming Events for the Week of August 4
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
Upcoming Catalysts and Commercial Launch in Sight; Buy
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
Exact Sciences Second Quarter, Rearing to Go on FDA Approval
Provider: The Benchmark Company
Analyst: WALD J
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
2Q14 Recap - Inspection Complete, Teeing Up Near-Term Approval.
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
2Q14 Preview - Expecting Clarity on Facility Inspection Timing - Payor Discussions Intrigue Us - Maintain N
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
2Q 2014: Quarterly Medical Technology Trading & Acquisition Valuation UpdateThis report contains brief updates on the following: ALGN, BABY, ETRM, EXAS, ICUI, LMAT, MASI, NSPH, TEAR, TRIB, UPI, VOLC. These companies are covered in more detail in separate Daily Notes and/or Company Reports.
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
The Week Ahead in Life Sciences - Upcoming Events for the Week of July 14
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
The Week Ahead in Life Sciences - Upcoming Events for the Week of July 14
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
LIFE SCIENCES AND HEALTH CARE
Provider: WEDBUSH SECURITIES INC.
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
Downgrading to NEUTRAL from OUTPERFORM - Taking a Breather After Stock Reaches PT and While We Wait for Approval and Preliminary Coverage Decision
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
Downgrading to NEUTRAL from OUTPERFORM - Taking a Breather After Stock Reaches PT and While We Wait for Approval and Preliminary Coverage Decisio
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
The Week Ahead in Life Sciences - Upcoming Events for the Week of May 26
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
The Week Ahead in Life Sciences - Upcoming Events for the Week of May 19
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L